» Articles » PMID: 39219286

Multidisciplinary Approaches to Study Anaemia with Special Mention on Aplastic Anaemia (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2024 Sep 2
PMID 39219286
Authors
Affiliations
Soon will be listed here.
Abstract

Anaemia is a common health problem worldwide that disproportionately affects vulnerable groups, such as children and expectant mothers. It has a variety of underlying causes, some of which are genetic. A comprehensive strategy combining physical examination, laboratory testing (for example, a complete blood count), and molecular tools for accurate identification is required for diagnosis. With nearly 400 varieties of anaemia, accurate diagnosis remains a challenging task. Red blood cell abnormalities are largely caused by genetic factors, which means that a thorough understanding requires interpretation at the molecular level. As a result, precision medicine has become a key paradigm, utilising artificial intelligence (AI) techniques, such as deep learning and machine learning, to improve prognostic evaluation, treatment prediction, and diagnostic accuracy. Furthermore, exploring the immunomodulatory role of vitamin D along with biomarker‑based molecular techniques offers promising avenues for insight into anaemia's pathophysiology. The intricacy of aplastic anaemia makes it particularly noteworthy as a topic deserving of concentrated molecular research. Given the complexity of anaemia, an integrated strategy integrating clinical, laboratory, molecular, and AI techniques shows a great deal of promise. Such an approach holds promise for enhancing global anaemia management options in addition to advancing our understanding of the illness.

Citing Articles

A potential predictive model based on machine learning and CPD parameters in elderly patients with aplastic anemia and myelodysplastic neoplasms.

Qi Y, Liu X, Ding Z, Yu Y, Zhuang Z BMC Med Inform Decis Mak. 2024; 24(1):379.

PMID: 39695587 PMC: 11654282. DOI: 10.1186/s12911-024-02781-z.

References
1.
Durrani J, Maciejewski J . Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program. 2019; 2019(1):97-104. PMC: 6913491. DOI: 10.1182/hematology.2019000019. View

2.
Tabata S, Hosoi H, Murata S, Takeda S, Mushino T, Sonoki T . Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?. J Autoimmun. 2021; 126:102782. PMC: 8668346. DOI: 10.1016/j.jaut.2021.102782. View

3.
Wang B, Wang C, Wan Y, Gao J, Ma Y, Zhang Y . Decoding the pathogenesis of Diamond-Blackfan anemia using single-cell RNA-seq. Cell Discov. 2022; 8(1):41. PMC: 9085895. DOI: 10.1038/s41421-022-00389-z. View

4.
Li J, Bledsoe J . Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist. Semin Diagn Pathol. 2023; 40(6):429-442. DOI: 10.1053/j.semdp.2023.06.006. View

5.
Ganapathi K, Townsley D, Hsu A, Arthur D, Zerbe C, Cuellar-Rodriguez J . GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2014; 125(1):56-70. PMC: 4281830. DOI: 10.1182/blood-2014-06-580340. View